NewAmsterdam Pharma Company's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; NewAmsterdam Pharma Company is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	$ -1.99M	$ -344.62K	$ -454.57K
EBITDA	-	-	$ -1.99M	$ -344.62K	$ -454.57K
Net Income Common Stockholders	-	-	$ -1.17M	$ 1.38M	$ 929.70K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 438.52M	-	$ 615.44K	$ 788.04K	$ 1.23M
Total Assets	$ 531.58M	-	$ 138.90M	$ 139.06M	$ 139.51M
Total Debt	$ 118.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -438.40M	$ 0.00	$ -615.44K	$ -788.04K	$ -1.23M
Total Liabilities	$ 650.94M	-	$ 7.05M	$ 6.03M	$ 7.86M
Stockholders Equity	$ -119.36M	-	$ 131.85M	$ 133.03M	$ 131.64M
Cash Flow	-
Free Cash Flow	-	-	$ -172.60K	$ -393.68K	$ 591.13K
Operating Cash Flow	-	-	$ -172.60K	$ -393.68K	$ 591.13K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	$ 0.00	$ -45.00K	-

Currency in USD

NewAmsterdam Pharma Company Earnings and Revenue History

Income Statement >

NewAmsterdam Pharma Company Debt to Assets

Balance Sheet >

NewAmsterdam Pharma Company Cash Flow

Cash Flow >

NewAmsterdam Pharma Company Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing